Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis

BACKGROUND: Refractory disease in primary central nervous system lymphoma (PCNSL) may occur despite adequate initial treatment. There is currently no standard of care for relapsed and recurrent PCSNL. No study to date documents using a combined regimen of radiotherapy, temozolomide, and rituximab. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Batara, Julette Marie F, Apor, Almira Doreen Abigail O, Mojica, Christianne V, Mondia, Mark Willy L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307100/
https://www.ncbi.nlm.nih.gov/pubmed/35892049
http://dx.doi.org/10.1093/noajnl/vdac105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307100/
https://www.ncbi.nlm.nih.gov/pubmed/35892049
http://dx.doi.org/10.1093/noajnl/vdac105

Ejemplares similares